SEC Form 4 · accession 0001645627-18-000061

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · 10% Owner

Period of report

Sep 26, 2018

Accepted (ET)

Oct 2, 2018 · 4:42 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001528172

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Sep 26, 2018	P	1,000	$0.0618	A	25,949,898	D
Common Stock	Sep 26, 2018	P	1,000	$0.0618	A	25,950,898	D
Common Stock	Sep 26, 2018	P	1,000	$0.0616	A	25,951,898	D
Common Stock	Sep 26, 2018	P	1,000	$0.0616	A	25,952,898	D
Common Stock	Sep 26, 2018	P	1,000	$0.0608	A	25,953,898	D
Common Stock	Sep 26, 2018	P	1,000	$0.0593	A	25,954,898	D
Common Stock	Sep 26, 2018	P	1,000	$0.0596	A	25,955,898	D
Common Stock	Sep 26, 2018	P	1,000	$0.0599	A	25,956,898	D
Common Stock	Sep 26, 2018	P	2,000	$0.0534	A	25,958,898	D
Common Stock	Sep 26, 2018	P	2,000	$0.0592	A	25,960,898	D
Common Stock	Sep 26, 2018	P	2,000	$0.0593	A	25,962,898	D
Common Stock	Sep 27, 2018	P	1,000	$0.0549	A	25,963,898	D
Common Stock	Sep 27, 2018	P	1,000	$0.0548	A	25,964,898	D
Common Stock	Sep 27, 2018	P	1,000	$0.0581	A	25,965,898	D
Common Stock	Sep 27, 2018	P	1,000	$0.0552	A	25,966,898	D
Common Stock	Sep 27, 2018	P	1,000	$0.0552	A	25,967,898	D
Common Stock	Sep 27, 2018	P	1,000	$0.0552	A	25,968,898	D
Common Stock	Sep 27, 2018	P	1,000	$0.0552	A	25,969,898	D
Common Stock	Sep 27, 2018	P	1,000	$0.0552	A	25,970,898	D

No Table II lines on this filing.